The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCINE.L Regulatory News (CINE)

  • There is currently no data for CINE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Receipt of Anschutz written consent

2 Feb 2018 17:44

RNS Number : 8428D
Cineworld Group plc
02 February 2018
 

PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT

FOR IMMEDIATE RELEASE

 

Cineworld Group plc (the "Company")

Receipt of Anschutz written consent

2 February 2018

The Company is pleased to announce that The Anschutz Corporation, the largest shareholder of Regal Entertainment Group ("Regal"), has delivered its written consent to approve the acquisition of Regal by the Company (the "Acquisition"), and that this consent has become effective following the passing of the Resolutions at the General Meeting of the Company held earlier today. All Company and Regal shareholder approvals necessary to proceed with the Transaction have now been received, and completion of the Acquisition is currently expected to occur on or prior to 2 March 2018.

 

A copy of this announcement will be displayed shortly on the Company's website at www.cineworldplc.com.

Capitalised terms used in this announcement have the meanings given to them in the combined prospectus and class 1 circular dated 17 January 2018 (the "Prospectus"), which is available on the Company's website (www.cineworldplc.com) and may be inspected at the registered office of the Company at 8th Floor, Vantage London, Great West Road, Brentford TW8 9AG during normal business hours on any Business Day up to and including the date ofRe-admission.

For further details please contact:

Cineworld Group plc

+44 (0)20 8987 5000

Israel Greidinger

 

Nisan Cohen

 

 

 

 

 

 

 

Barclays (Joint Financial Adviser, Joint Underwriter, Joint Global Coordinator and Joint Corporate Broker to Cineworld)

+44 (0)20 7623 2323

Makram Azar

 

Daniel Ross

 

Mark Astaire

 

James Colburn

 

 

 

 

 

HSBC (Joint Financial Adviser, Joint Underwriter and Joint Global Coordinator to Cineworld)

+44 (0)20 7991 8888

Philip Noblet

 

Noam Kleinfeld

 

James Thomlinson

 

Mark Dickenson

 

Sam Barnett

 

 

 

Investec Bank plc (Sponsor, Joint Underwriter, Joint Bookrunner and Joint Corporate Broker to Cineworld)

+44 (0)20 7597 4000

 

 

Chris Sim

 

George Price

 

Jonathan Wynn

 

Robert Baker

 

 

 

 

 

Powerscourt (Public Relations Adviser to Cineworld)

+44 (0)20 7250 1446

 

 

Nick Dibden

 

Rob Greening

 

Lisa Kavanagh

 

 

IMPORTANT NOTICE

The contents of this announcement have been prepared by and are the sole responsibility of Cineworld.

The information contained in this announcement is for background purposes only and does not purport to be full or complete. No reliance may be placed by any person for any purpose on the information contained in this announcement or its accuracy, fairness or completeness.

Neither the content of Cineworld's website nor any website accessible by hyperlinks on Cineworld's website is incorporated in, or forms part of, this announcement.

Each of Barclays Bank PLC, acting through its Investment Bank ("Barclays"), HSBC Bank plc ("HSBC") and Investec Bank plc ("Investec" and together with Barclays and HSBC, the "Underwriters") is authorised by the Prudential Regulation Authority and regulated in the United Kingdom by the Financial Conduct Authority and the Prudential Regulation Authority. Each of the Underwriters is acting exclusively for Cineworld and no one else in connection with the Transaction or any other matter referred to in this announcement and will not be responsible to anyone other than Cineworld for providing the protections afforded to their respective clients nor for providing advice in relation to the Transaction or any other matter referred to in this announcement. Neither the Underwriters nor any of their respective subsidiaries, branches or affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of the Underwriters in connection with this announcement, any statements contained herein or otherwise.

Information to Distributors

Solely for the purposes of the product governance requirements contained within: (a) EU Directive 2014/65/EU on markets in financial instruments, as amended ("MiFID II"); (b) Articles 9 and 10 of Commission Delegated Directive (EU) 2017/593 supplementing MiFID II; and (c) local implementing measures (together, the "MiFID II Product Governance Requirements"), and disclaiming all and any liability, whether arising in tort, contract or otherwise, which any "manufacturer" (for the purposes of the MiFID II Product Governance Requirements) may otherwise have with respect thereto, the Nil Paid Rights, the Fully Paid Rights and the New Ordinary Shares have been subject to a product approval process, which has determined that they each are: (i) compatible with an end target market of retail investors and investors who meet the criteria of professional clients and eligible counterparties, each as defined in MiFID II; and (ii) eligible for distribution through all distribution channels as are permitted by MiFID II (the "Target Market Assessment"). Notwithstanding the Target Market Assessment, Distributors should note that: the price of the Nil Paid Rights, the Fully Paid Rights and/or the New Ordinary Shares may decline and investors could lose all or part of their investment; the Nil Paid Rights, the Fully Paid Rights and the New Ordinary Shares offer no guaranteed income and no capital protection; and an investment in the Nil Paid Rights, the Fully Paid Rights and/or the New Ordinary Shares is compatible only with investors who do not need a guaranteed income or capital protection, who (either alone or in conjunction with an appropriate financial or other adviser) are capable of evaluating the merits and risks of such an investment and who have sufficient resources to be able to bear any losses that may result therefrom. The Target Market Assessment is without prejudice to the requirements of any contractual, legal or regulatory selling restrictions in relation to the offer. Furthermore, it is noted that, notwithstanding the Target Market Assessment, the Underwriters will only procure investors who meet the criteria of professional clients and eligible counterparties. For the avoidance of doubt, the Target Market Assessment does not constitute: (a) an assessment of suitability or appropriateness for the purposes of MiFID II; or (b) a recommendation to any investor or group of investors to invest in, or purchase, or take any other action whatsoever with respect to the Nil Paid Rights, the Fully Paid Rights and/or the New Ordinary Shares. Each distributor is responsible for undertaking its own target market assessment in respect of the Nil Paid Rights, the Fully Paid Rights and/or the New Ordinary Shares and determining appropriate distribution channels.The person responsible for this announcement is Fiona Smith, Company Secretary of Cineworld.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFSDFFIFIIT
Date   Source Headline
28th Feb 20185:07 pmRNSCompletion of Acquisition of Regal Entertainment
23rd Feb 201812:59 pmRNSTR-1: Standard Form of Notification
23rd Feb 201812:56 pmRNSTR-1: Standard Form of Notification
22nd Feb 20184:34 pmRNSTR-1: Standard Form of Notification
22nd Feb 20184:32 pmRNSTR-1: Standard Form of Notification
22nd Feb 20184:31 pmRNSTR-1: Standard Form of Notification
21st Feb 20182:54 pmRNSTR-1: Standard Form of Notification
20th Feb 20184:53 pmRNSTR-1: Standard Form of Notification
20th Feb 20184:17 pmRNSPDMR/Director Shareholding
20th Feb 20182:39 pmRNSResults of Rump Placing
20th Feb 20187:00 amRNSResults of Rights Issue
16th Feb 20186:02 pmRNSPDMR/Director Shareholding
13th Feb 20185:42 pmRNSPDMR/Director Shareholding
12th Feb 20186:23 pmRNSPDMR/Director Shareholding
9th Feb 20184:19 pmRNSPDMR/Director Shareholding
8th Feb 201812:57 pmRNSTR-1: Notification of major holdings
6th Feb 201810:36 amRNSTR-1: Standard Form of Notification
5th Feb 201812:08 pmRNSTR-1: Standard Form of Notification
2nd Feb 20185:44 pmRNSReceipt of Anschutz written consent
2nd Feb 201811:13 amRNSResults of General Meeting
1st Feb 201810:56 amRNSTotal Voting Rights
29th Jan 201810:58 amRNSTR-1: Standard Form of Notification
24th Jan 201810:20 amRNSTR-1: Standard Form of Notification
22nd Jan 20182:55 pmRNSTR-1: Standard Form of Notification
19th Jan 20185:12 pmRNSDirector/PDMR Shareholding
19th Jan 20182:02 pmRNSHolding(s) in Company
17th Jan 20182:42 pmRNSCombined Prospectus and Class 1 Circular
17th Jan 20187:09 amRNSRights Issue Announcement
17th Jan 20187:00 amRNSTrading Statement
5th Jan 20184:09 pmRNSTR-1: Standard Form of Notification
2nd Jan 20188:57 amRNSTotal Voting Rights
5th Dec 20177:18 amRNSProposed acquisition of Regal Entertainment Group
1st Dec 20176:08 pmRNSTotal Voting Rights
29th Nov 20177:00 amRNSPossible offer for Regal Entertainment Group
27th Nov 20177:00 amRNSBlock Listing Six Monthly Return
23rd Nov 20177:00 amRNSTrading update
17th Nov 20173:54 pmRNSHolding(s) in Company
1st Nov 20171:25 pmRNSTotal Voting Rights
2nd Oct 20174:31 pmRNSTotal Voting Rights
12th Sep 20177:00 amRNSHolding(s) in Company
7th Sep 20172:09 pmRNSHolding(s) in Company
1st Sep 20179:29 amRNSTotal Voting Rights
14th Aug 20172:55 pmRNSAllotment and Issue of New Ordinary Shares
10th Aug 20177:00 amRNSHalf-year Report
1st Aug 201711:04 amRNSTotal Voting Rights
28th Jul 201712:45 pmRNSHolding(s) in Company
5th Jul 20179:11 amRNSPDMR/Director Shareholding
3rd Jul 201710:23 amRNSTotal Voting Rights
23rd Jun 20176:25 pmRNSDirector/PDMR Shareholding
14th Jun 201711:56 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.